neoBLUE compact LED Phototherapy System by NATUS MEDICAL INCORPORATED
The neoBLUE compact LED Phototherapy System is a premier medical device from Natus Medical Incorporated, engineered to provide immediate and effective treatment for newborns with jaundice. This pioneering product makes use of high-intensity light-emitting diodes (LEDs), providing optimal blue light for maximum therapeutic efficacy.
The neoBLUE system stands at the forefront of neonatal care, employing a targeted and safe spectrum of LED phototherapy, reducing the risk of skin damage and potential retinal injury associated with phototherapy. The device ensures efficient treatment via the delivery of high-intensity illumination over a generous defined treatment area.
Beyond its superior treatment capabilities, this system features a compact and lightweight yet robust design. It integrates seamlessly into existing workflows, capable of operating while infants continue to receive care in incubators, radiant warmers and even in the mother's arms. The neoBLUE compact system does not emit ultraviolet (UV) or infrared (IR) light, emphasizing the company's commitment to safety.
Moreover, the product adopts an economical approach, boasting energy efficiency and durable LEDs that do not require replacement. This translates into lower operational costs and less environmental impact, making it a smart choice for healthcare providers that aim for sustainable practices.
To summarize, the neoBLUE Compact LED Phototherapy System embodies a culmination of safe, effective, and user-friendly technology, striving to achieve optimum health outcomes for neonates with hyperbilirubinemia or jaundice.
Primary Use:
neoBLUE Compact LED Phototherapy System
The neoBLUE Compact LED Phototherapy System is a primary-level medical device designed specifically to provide treatment for neonates suffering from hyperbilirubinemia, commonly referred to as jaundice. Its main function is to deliver intensive blue light therapy, utilizing its innovative LED light technology for optimal bilirubin decomposition.
Medical Importance and Efficiency
The pivotal role of the neoBLUE Compact LED Phototherapy System lies in its exceptional ability to emanate a blue light with a narrow bandwidth (approximately 450-470 nm). This specific range has been clinically proven to be the most effective in reducing high bilirubin levels in the bloodstream.
The treatment process is simple yet powerful. The system emits focused, high-intensity blue light, which the neonate's skin absorbs. The light catalyzes a reaction that changes bilirubin into a form that the infant's body can easily eliminate. Through these means, the device significantly helps to prevent severe jaundic complications such as kernicterus.
Design and Functionality
Notably, the neoBLUE Compact LED Phototherapy System boasts a sleek and compact design, providing unrivaled versatility and space efficiency within the neonatal care setting. Its practical design represents the meeting point between high operational efficacy and ease-of-use, thereby assuring minimal downtime during critical treatment phases. With its long-lasting LEDs, the system offers thousands of hours of high-intensity illumination, eliminating the need for routine lamp replacements and ensuring continued, uninterrupted therapy sessions for neonates.
In summary, the neoBLUE Compact LED Phototherapy System represents a major advancement in neonatal care, providing an effective, efficient, and reliable solution for treating neonatal jaundice. It stands as an invaluable addition to any medical practice focused on neonatal care.
How It Works:
Introduction to neoBLUE compact LED Phototherapy System
The neoBLUE compact LED Phototherapy Systemis a cutting edge medical device designed for neonatal intensive care units and pediatric wards. This specialized piece of equipment delivers a high intensity blue light used to treat neonatal jaundice, a common condition seen in newborns. How does the neoBLUE Compact LED Phototherapy System Work?
Phototherapy is an established treatment method for jaundiced infants, where light wavelengths are optimized to convert the yellow pigment, bilirubin, into a water-soluble form. The neoBLUE compact LED Phototherapy System has been engineered to provide high-intensity blue light (wavelength: 450 - 470nm), the most effective spectrum for the degradation of bilirubin.
Key Features of the neoBLUE compact LED Phototherapy System
Designed with efficacy and safety in mind, the neoBLUE compact LED Phototherapy System offers unique features that separate it from other phototherapy systems currently available in the market.
1. High intensity blue LEDs:
The system utilizes blue light-emitting diodes (LEDs) that produce the precise light spectrum and intensity necessary for effective bilirubin photoisomerization—the chemical process that turns bilirubin into a form that can be excreted by the newborn's body.
2. Compatibility and convenience:
The compact design facilitates integration into a variety of clinical environments. The system is compatible with most types of neonatal enclosures, including incubators, radiant warmers, and bassinets.
3. Optimized light delivery:
The neoBLUE compact system's overhead configuration allows for uniform light distribution over the maximum body surface area, optimizing the therapeutic effect.
Conclusion
The neoBLUE compact LED Phototherapy System represents the cutting-edge of neonatal care technology. It is an efficient, safe, and compact device that delivers an optimal light spectrum designed to mitigate neonatal jaundice. Adoption of this technology should lead to more effective, targeted treatment protocols, improving patient outcomes in the process.
Manufacturer:
NATUS MEDICAL INCORPORATED
Status: In Stock
Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.